Home > Insider Trading > Filing (0001190725-16-000301)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1576263	Mirati Therapeutics Inc.	MRTX	Pharmaceutical Preparations (2834)	462693615

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1373110	J Mark Gergen	9393 Towne Centre Dr Ste 200 San Diego CA 92121	Executive Vp, Coo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-01-15	5,000	$8.50	5,748	No	4	M	Direct
Common Stock	Acquisiton	2016-01-15	10,000	$8.50	15,748	No	4	M	Direct
Common Stock	Disposition	2016-01-15	10,000	$25.92	5,748	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Incentive Stock Option (right to buy)	Acquisiton	2016-01-15	5,000	$0.00	5,000	$8.50
Common Stock	Non Qualified Stock Option (right to buy)	Acquisiton	2016-01-15	10,000	$25.92	10,000	$8.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
127,000		2020-07-16	No	4	M	Direct
117,000		2020-07-16	No	4	M	Direct

Footnotes

20% of the shares subject to the option vested and became exercisable on the Date of Grant, and 20% of tbe shares vest on each of the 1st, 2nd, 3rd and 4th anniversaries of February 15, 2013
The price quoted in Table 1, Column 4 and Table 2, Column 8 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $27.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.